Genge Partners Inc.

Futó vizsgálatok

• Toboroz

  A Study of Trontinemab in Cognitively Unimpaired Individuals at Risk for Progression to Symptomatic Alzheimer's Disease

  NCT07717411· 3. fázis· Forrás

• Fut, nem toboroz

  A Clinical Trial of Trontinemab in Participants With Early Symptomatic Alzheimer's Disease

  NCT07170150· 3. fázis· Forrás

• Toboroz

  Screening Study to Determine Individuals With Potential Trial Eligibility for Alzheimer's Disease Studies

  NCT07177352· 3. fázis· Forrás

• Fut, nem toboroz

  A Phase 3 Study to Evaluate the Efficacy and Safety of Efgartigimod IV in Patients With Acetylcholine Receptor Binding Antibody Seronegative Generalized Myasthenia Gravis

  NCT06298552· 3. fázis· Forrás

• Fut, nem toboroz

  A Study to Evaluate the Effectiveness and Safety of Dysport® for the Prevention of Chronic Migraine in Adults

  NCT06047444· 3. fázis· Forrás

• Fut, nem toboroz

  A Study to Evaluate the Effectiveness and Safety of Dysport® for the Prevention of Episodic Migraine in Adults

  NCT06047457· 3. fázis· Forrás

• Toboroz

  Development of a Novel Functional Eye-Tracking Software Application for Multiple Sclerosis

  NCT05061953· Forrás

Egyszerre toboroz

Hány vizsgálat toboroz itt egyszerre ugyanarra az indikációra. Darabszám, nem értékelés.

• Alzheimer-kór2 toboroz
• Sclerosis multiplex (SM)1 toboroz

Kutatók

Ide még nem kötődik kutató.

Lezárt vizsgálatok

• Lezárult

  Eye-tracking Investigation of Clinical Measures in Multiple Sclerosis

  NCT06283524· Forrás

• Lezárult

  Safety and Efficacy of NMD670 in Ambulatory Adult Patients With Type 3 Spinal Muscular Atrophy

  NCT05794139· 2. fázis· Forrás

• Lezárult

  Investigating Eye-Movement Biomarkers of Disease Severity and Cognition in Multiple Sclerosis

  NCT05661266· Forrás